Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Thermo Fisher Scientific Inc | 1,114 |
| 2 | Ionis Pharmaceuticals Inc | 833 |
| 3 | Harvard University | 694 |
| 4 | University of California | 393 |
| 5 | Massachusetts Institute of Technology | 348 |
| 6 | Sanofi SA | 328 |
| 7 | Roche Holding AG | 327 |
| 8 | Labcorp Holdings Inc | 301 |
| 9 | Mass General Brigham Inc | 287 |
| 10 | Alnylam Pharmaceuticals Inc | 271 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 10,669 |
| 2 | A61K | Medicinal preparations | 9,347 |
| 3 | A61P | Therapeutic activity (drug indications) | 8,211 |
| 4 | C12Q | Measuring/testing involving enzymes | 6,913 |
| 5 | C07K | Peptides | 5,407 |
| 6 | C07H | Sugars and derivatives | 3,352 |
| 7 | G01N | Investigating / analysing materials | 2,810 |
| 8 | C12Y | Enzyme nomenclature (EC numbers) | 2,365 |
| 9 | C07D | Heterocyclic compounds | 1,438 |
| 10 | C12P | Fermentation, enzyme processes | 1,371 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| 2-halo-2'-deoxyadenosines in the treatment of rheumatoid arthritis | 1994 | Scripps Research Institute | 62 |
| Method for the production of 2'-deoxyadenosine compounds | 1988 | Brigham Young University | 38 |
| Method for the production of 2'-deoxyadenosine compounds | 1986 | Brigham Young University | 36 |
| 2-halo-2'-deoxyadenosines in the treatment of monocyte-mediated inflammatory disease conditions | 1996 | Scripps Research Institute | 24 |
| 2-Halo-2'-deoxyadenosines as therapeutic agents against malignant astrocytoma | 1995 | Scripps Research Institute | 19 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 15 |
| 2017 | 8 |
| 2018 | 12 |
| 2019 | 14 |
| 2020 | 8 |
| 2021 | 7 |
| 2022 | 4 |
| 2024 | 4 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Jayant S Kulkarni | Wayne State University | 6 |
| 2 | Yoshio Saitō | Nihon University | 5 |
| 3 | Erik De Clercq | Rega Institute for Medical Research | 5 |
| 4 | Arun R. Wakade | Wayne State University | 5 |
| 5 | Rodney E. Kellems | Baylor College of Medicine | 4 |
| 6 | Piet Herdewijn | Rega Institute for Medical Research | 4 |
| 7 | Ashok Agarwal | Cleveland Clinic | 4 |
| 8 | Zbigniew J. Leśnikowski | Polish Academy of Sciences | 4 |
| 9 | Jean Cadet | CEA Grenoble | 4 |
| 10 | Maria Grazia Tozzi | University of Pisa | 4 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Staphylococcus aureus Degrades Neutrophil Extracellular Traps to Promote Immune Cell Death | 2013 | 414 | Immune cells in cancer |
| Phosphorothioation of DNA in bacteria by dnd genes | 2007 | 276 | RNA and protein synthesis mechanisms |
| N6-Deoxyadenosine Methylation in Mammalian Mitochondrial DNA | 2020 | 250 | Epigenetics and DNA Methylation |
| Structural insights into FTO’s catalytic mechanism for the demethylation of multiple RNA substrates | 2019 | 249 | Cancer-related molecular mechanisms research |
| Peroxynitrite Mediated Oxidation of Purine Bases of Nucleosides and Isolated DNA | 1996 | 178 | Nitric Oxide and Endothelin Effects |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of deoxyadenosine?
Which organizations have filed the most patents involving deoxyadenosine?
What are the key research topics associated with deoxyadenosine in the academic literature?
How has patent activity for deoxyadenosine changed in recent years?
What therapeutic applications have been explored in deoxyadenosine-related patents?